Suicide risk among urinary bladder cancer patients compared with the standard population: a nationwide study in Sweden
Scandinavian Journal of Urology · 2025
DOI: 10.2340/sju.v60.44784 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Scandinavian Journal of Urology, 2025. Verfasst von Lewar Hawez und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgical Sciences, Urology, Uppsala University, Uppsala, Sweden. lewar.hawez@uu.se. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, Suicide. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Objective
To assess the risk of suicide after a diagnosis of urinary bladder cancer (UBC) compared with the standard population and to identify potential risk factors and time dependence associated with suicide in patients with UBC.
Method
We used data from the Bladder Cancer Data Base Sweden 2.0 (BladderBaSe), including all individuals aged 18 years or older, diagnosed with UBC between 1997 and 2019. Suicides were identified using ICD-10 codes X60-X84. We compared the number of suicides identified in BladderBaSe with the expected number in a Swedish standard population of the same age and sex distribution during the same period. Outcome measurements: The risk of suicide was determined using standardized mortality ratios (SMR) with 95% confidence intervals (CI).
Results
Among 53,298 patients with UBC included in our study, 106 suicides were identified compared with an expected 66 in the standard population (SMR: 1.6; 95% CI: 1.31–1.93). The risk of suicide was highest within the first 4 weeks after diagnosis (SMR: 4.66; 95% CI: 2.48–7.97), in patients with advanced UBC (SMR: 5.64; 95% CI: 2.06–12.3), those receiving palliative treatment (SMR: 5.03; 95% CI: 2.51–9.01), and those living alone (SMR: 2.87; 95% CI: 2.22 - 3.66).
Conclusion
The suicide risk among UBC patients is significantly elevated and shaped by multiple factors, with the highest risk observed in the first 4 weeks from diagnosis. Healthcare providers should maintain heightened vigilance for suicidal ideation, particularly during the critical period immediately following diagnosis, to ensure timely support and intervention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Surgical Sciences, Urology, Uppsala University, Uppsala, Sweden. lewar.hawez@uu.se.
- Department of Surgical Sciences, Urology, Uppsala University, Uppsala, Sweden.
- Department of Surgical Sciences, Urology, Uppsala University, Uppsala, Sweden; Regional Cancer Centre, Uppsala University Hospital, Uppsala, Sweden.
- Translational Oncology and Urology Research (TOUR), King's College London, London, UK.
- Department of Clinical Neuroscience, Stockholm Centre for Psychiatric Research and Education, Karolinska Institute, Stockholm, Sweden.
- Department of Clinical Sciences, Danderyd Hospital, Karolinska Institute, Stockholm, Sweden.
Zitieren
APA
Hawez, L., Bergengren, O., Ahlberg, M., Garmo, H., Van Hemelrijck, M., Nyberg, U. K., Gardmark, T., Holmberg, L., Liedberg, F., & Bill-Axelson, A. (2025). Suicide risk among urinary bladder cancer patients compared with the standard population: a nationwide study in Sweden. Scandinavian Journal of Urology. https://doi.org/10.2340/sju.v60.44784
Vancouver
Hawez L, Bergengren O, Ahlberg M, Garmo H, Van Hemelrijck M, Nyberg UK, et al. Suicide risk among urinary bladder cancer patients compared with the standard population: a nationwide study in Sweden. Scandinavian Journal of Urology. 2025. doi:10.2340/sju.v60.44784
BibTeX
@article{Hawez2025,
author = {Hawez, Lewar and Bergengren, Oskar and Ahlberg, Mats and Garmo, Hans and Van Hemelrijck, Mieke and Nyberg, Ulla-Karin and Gardmark, Truls and Holmberg, Lars and Liedberg, Fredrik and Bill-Axelson, Anna},
title = {Suicide risk among urinary bladder cancer patients compared with the standard population: a nationwide study in Sweden},
journal = {Scandinavian Journal of Urology},
year = {2025},
doi = {10.2340/sju.v60.44784}
}
EUVIMED